Literature DB >> 19404948

Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.

John D Carter1, Hervé C Gérard, Luis R Espinoza, Louis R Ricca, Joanne Valeriano, Jessica Snelgrove, Cynthia Oszust, Frank B Vasey, Alan P Hudson.   

Abstract

OBJECTIVE: The majority of patients with Chlamydia-induced reactive arthritis do not present with the classic triad of arthritis, conjunctivitis/iritis, and urethritis. Moreover, acute chlamydial infections are often asymptomatic. The aim of the present study was to assess the prevalence of synovial Chlamydia trachomatis and Chlamydia pneumoniae infections in patients with chronic undifferentiated spondylarthritis (uSpA).
METHODS: Study patients met the European Spondylarthropathy Study Group criteria for SpA, without evidence of ankylosing spondylitis, psoriasis, inflammatory bowel disease, or preceding dysentery. Symptoms were present for >or=6 months. Each patient underwent a synovial biopsy; tissue and concomitantly obtained peripheral blood mononuclear cells (PBMCs) were analyzed by polymerase chain reaction (PCR) for C trachomatis and C pneumoniae DNA. Other data collected on the day of the biopsy included standard demographic information and medical history, including any known history of C trachomatis or C pneumoniae. Physical examination (including joint count, evaluation for dactylitis and/or enthesitis, and skin examination) and HLA-B27 typing were performed. Synovial tissue (ST) samples from 167 patients with osteoarthritis (OA) were used as controls.
RESULTS: Twenty-six patients met the entry criteria and underwent synovial biopsy (25 knee, 1 wrist). Sixteen of them (62%) were positive for C trachomatis and/or C pneumoniae DNA (10 for C trachomatis, 4 for C pneumoniae, and 2 for both). PCR analysis of ST revealed the presence of Chlamydia significantly more frequently in patients with uSpA than in OA controls (P<0.0001). No specific clinical characteristics differentiated Chlamydia-positive from Chlamydia-negative patients. PBMCs from 4 of the 26 uSpA patients (15%) were positive for Chlamydia, and Chlamydia was found in ST from 2 of these 4 patients. No significant correlation between PCR positivity and HLA-B27 positivity was found.
CONCLUSION: The frequency of Chlamydia-positive ST samples, as determined by PCR, was found to be significantly higher in patients with uSpA than in patients with OA. Our results suggest that in many patients with uSpA, chlamydial infection, which is often occult, may be the cause.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404948      PMCID: PMC2757404          DOI: 10.1002/art.24431

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

1.  Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.

Authors:  Hervé C Gérard; Julia Freise; Zhao Wang; George Roberts; Debbi Rudy; Birgit Krauss-Opatz; Lars Köhler; Henning Zeidler; H Ralph Schumacher; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Microbes Infect       Date:  2002-01       Impact factor: 2.700

Review 2.  Screening for chlamydial infection.

Authors:  H D Nelson; M Helfand
Journal:  Am J Prev Med       Date:  2001-04       Impact factor: 5.043

Review 3.  Seronegative spondyloarthritides.

Authors:  Ignazio Olivieri; Astrid van Tubergen; Carlo Salvarani; Sjef van der Linden
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-12       Impact factor: 4.098

Review 4.  Seronegative polyarthritis: a unified concept.

Authors:  V Wright
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

5.  Needle biopsy of the synovial membrane--experience with the Parker-Pearson technic.

Authors:  H R Schumacher; J P Kulka
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

Review 6.  Chlamydia pneumoniae as a respiratory pathogen.

Authors:  David L Hahn; Anthony A Azenabor; Wandy L Beatty; Gerald I Byrne
Journal:  Front Biosci       Date:  2002-03-01

7.  Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period.

Authors:  Michele F Doran; Gregory R Pond; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2002-03

8.  Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults.

Authors:  N Miyashita; Y Niki; M Nakajima; H Fukano; T Matsushima
Journal:  Chest       Date:  2001-05       Impact factor: 9.410

9.  Annual incidence of inflammatory joint diseases in a population based study in southern Sweden.

Authors:  M K Söderlin; O Börjesson; H Kautiainen; T Skogh; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

10.  Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections.

Authors:  Hervé C Gérard; Judith A Whittum-Hudson; H Ralph Schumacher; Alan P Hudson
Journal:  Microb Pathog       Date:  2004-01       Impact factor: 3.738

View more
  26 in total

1.  Remarkable polymorphism of HLA-B27: an ongoing saga.

Authors:  Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

Review 2.  New evidence on the management of spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

Review 3.  Spondyloarthropathies in 2010: new insights into therapy-TNF blockade and beyond.

Authors:  Joachim Sieper
Journal:  Nat Rev Rheumatol       Date:  2011-02       Impact factor: 20.543

Review 4.  Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.

Authors:  Jeffrey A Sparks; Karen H Costenbader
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

Review 5.  Chlamydia-Induced Reactive Arthritis: Disappearing Entity or Lack of Research?

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.592

6.  Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.

Authors:  Hervé C Gérard; Jessica A Stanich; Cynthia E Oszust; Judith A Whittum-Hudson; John D Carter; H Ralph Schumacher; Alan P Hudson
Journal:  Am J Med Sci       Date:  2010-12       Impact factor: 2.378

7.  Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome.

Authors:  Ivan M Petyaev; Nayilia A Zigangirova; Alexey M Petyaev; Ulia P Pashko; Lubov V Didenko; Elena U Morgunova; Yuriy K Bashmakov
Journal:  Int J Med Sci       Date:  2010-06-10       Impact factor: 3.738

8.  Undifferentiated spondyloarthritis following allogeneic stem cell transplantation.

Authors:  Vijay R Karia; Raquel Cuchacovich; Luis R Espinoza
Journal:  BMC Musculoskelet Disord       Date:  2010-06-25       Impact factor: 2.362

9.  The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.

Authors:  John D Carter; Herve C Gerard; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Int J Clin Rheumtol       Date:  2012-12-01

10.  Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.

Authors:  Hervé C Gerard; Jessica A Stanich; Judith A Whittum-Hudson; H Ralph Schumacher; John D Carter; Alan P Hudson
Journal:  Microb Pathog       Date:  2009-11-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.